Tasly Pharmaceutical Group Co., Ltd (SHA: 600535)

China flag China · Delayed Price · Currency is CNY
15.00
+0.09 (0.60%)
Nov 19, 2024, 3:00 PM CST
-0.13%
Market Cap 22.62B
Revenue (ttm) 8.57B
Net Income (ttm) 881.05M
Shares Out 1.49B
EPS (ttm) 0.59
PE Ratio 25.77
Forward PE 15.14
Dividend 0.52 (3.47%)
Ex-Dividend Date Oct 10, 2024
Volume 10,742,298
Open 14.91
Previous Close 14.91
Day's Range 14.78 - 15.05
52-Week Range 12.24 - 18.00
Beta 0.41
Analysts n/a
Price Target n/a
Earnings Date Oct 28, 2024

About Tasly Pharmaceutical Group

Tasly Pharmaceutical Group Co., Ltd engages in the pharmaceutical business in China and internationally. It provides cardiovascular, anti-tumor, cold and fever, liver disease treatment, and other disease solutions. Tasly Pharmaceutical Group Co., Ltd was founded in 1994 and is based in Tianjin, China. [Read more]

Sector Healthcare
Founded 1994
Employees 9,223
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600535
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.